Ubiquitin-specific protease 22 (USP22) positively regulates RCAN1 protein levels through RCAN1 de-ubiquitination

Journal of Cellular Physiology

Volumn 230, Issue 7, 2015, Pages 1651-1660

  Hong, Ahyoung ^a   Lee, Ji Eun ^a   Chung, Kwang Chul ^a  

^a Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA TRCP E3 LIGASE; CALCINEURIN INHIBITOR; DEUBIQUITINASE; FB87 UBIQUITIN PROTEIN LIGASE E3; LIGASE; PROTEASOME; REGULATOR OF CALCINEURIN 1 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE NEDD4; UBIQUITIN SPECIFIC PROTEASE 22; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; MUSCLE PROTEIN; RCAN1 PROTEIN, HUMAN; SIGNAL PEPTIDE; THIOL ESTER HYDROLASE; UBIQUITIN PROTEIN LIGASE; USP22 PROTEIN, HUMAN;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELETION MUTANT; DNA LIBRARY; ENZYME ACTIVITY; ENZYME DEGRADATION; FETUS; GENE OVEREXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEUBIQUITINATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; UBIQUITINATION; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

MAMMALIA;

CELL CYCLE PROTEINS; CELL LINE; F-BOX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-ALPHA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE PROTEINS; THIOLESTER HYDROLASES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84925652324     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24917     Document Type: Article

References (53)

1. Abbasi S, Lee JD, Su B, Chen X, Alcon JL, Yang J, Kellems RE, Yang X. 2006. Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. J Biol Chem 281:7717-7726.
2. Abbasi S, Su B, Kellems RE, Yang J, Xia Y. 2005. The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation. J Biol Chem 280:36737-36746.
3. Amerik AY, Hochstrasser M. 2004. Mechanism and function of de-ubiquitinating enzymes. Biochim Biophys Acta 1695:189-207.
4. Asada S, Ikeda A, Nagao R, Hama H, Sudo T, Fukamizu A, Kasuya Y, Kishi T. 2008. Oxidative stress-induced ubiquitination of RCAN1 mediated by SCFβ-TrCP ubiquitin ligase. Int J Mol Med 22:95-104.
5. Atanassov BS, Evrard YA, Multani AS, Zhang Z, Tora L, Devys D, Chang S, Dent SY. 2009. Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance. Mol Cell 35:352-364.
6. Baker SP, Grant PA. 2007. The SAGA continues: Expanding the cellular role of a transcriptional co-activator complex. Oncogene 26:5329-5340.
7. Daniel JA, Grant PA. 2007. Multi-tasking on chromatin with the SAGA coactivator complexes. Mutation Res 618:135-148.
8. Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, de la Luna S. 2000. DSCR1, over-expressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9:1681-1690.
9. Fuentes JJ, Pritchard MA, Estivill X. 1997. Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 44:358-361.
10. Fuentes JJ, Pritchard MA, Planas AM, Bosch A, Ferrer I, Estivill X. 1995. A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet 4:1935.
11. Gan-Erdene T, Nagamalleswari K, Yin L, Wu K, Pan ZQ, Wilkinson KD. 2003. Identification and characterization of DEN1, a deneddylase of the ULP family. J Biol Chem 278:28892-28900.
12. Genescà L, Aubareda A, Fuentes JJ, Estivill X, de la Luna S, Perez-Riba M. 2003. Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin decreases calcipressin half-life. Biochem J 374:567-575.
13. Gong B, Leznik E. 2007. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect 20:365-379.
14. Harris CD, Ermak G, Davies KJ. 2005. Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin1 (or RCAN1) in disease. Cell Mol Life Sci 62:2477-2486.
15. Henry KW, Wyce A, Lo WS, Duggan LJ, Emre NC, Kao CF, Pillus L, Shilatifard A, Osley MA, Berger SL. 2003. Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8. Genes Dev 17:2648-2663.
16. Hesser BA, Liang XH, Camenisch G, Yang S, Lewin DA, Scheller R, Ferrara N, Gerber HP. 2004. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood 104:149-158.
17. Hilioti Z, Gallagher DA, Low-Nam ST, Ramaswamy P, Gajer P, Kingsbury TJ, Birchwood CJ, Levchenko A, Cunningham KW. 2003. GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev 18:35-47.
18. Hirakawa Y, Nary LJ, Medh RD. 2009. Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis. J Mol Signal 4:6.
19. Ingvarsdottir K, Krogan NJ, Emre NC, Wyce A, Thompson NJ, Emili A, Hughes TR, Greenblatt JF, Berger SL. 2005. H2B ubiquitin protease Ubp8 and Sgf11 constitute a discrete functional module within the Saccharomyces cerevisiae SAGA complex. Mol Cell Biol 25:1162-1172.
20. Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, Xiao Y, Christie AL, Aster J, Settleman J, Gygi SP, Kung AL, Look T, Nakayama KI, DePinho RA, Wei W. 2011. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 471:104-109.
21. Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y. 1998. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-a novel ubiquitin hydrolase which binds to the BRCAmediated cell growth suppression. Oncogene 16:1097-1112.
22. Jung MS, Park JH, Ryu YS, Choi SH, Yoon SH, Ken MY, Oh JY, Song WJ, Chung SH. 2011. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation. J Biol Chem 286:40401-40412.
23. Kim SS, Seo SR. 2010. Nedd4-2 ubiquitin ligase interacts with RCAN1 (DSCR1) for the proteasomal degradation. Genes & Genomics 32:578-582.
24. Kimn SS, Oh Y, Chung KC, Seo SR. 2012. Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1). Biochem Biophys Res Commun 418:657-661.
25. Kishi T, Ikeda A, Nagao R, Koyama N. 2007. The SCFCdc4 ubiquitin ligase regulates calcineurin signaling through degradation of phosphorylated Rcn1 an inhibitor of calcineurin. Proc Natl Acad Sci 104:17418-17423.
26. Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, Elledge SJ. 2001. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294:173-177.
27. Komander D, Clague MJ, Urbe S. 2009. Breaking the chains: Structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10:550-563.
28. Lee JW, Kang HS, Lee JY, Lee EJ, Rhim H, Yoon JH, Seo SR, Chung KC. 2012. The transcription factor STAT2 enhances proteasomal degradation of RCAN1 through the ubiquitin E3 ligase FBW7. Biochem Biophy Res Commun 420:404-410.
29. Lee JY, Lee HJ, Lee EJ, Jang SH, Kim H, Yoon JH, Chung KC. 2009. Down syndrome candidate region-1 protein interacts with Tollip and positively modulates interleukin-1 receptor-mediated signaling. Biochim Biophys Acta 1790:1673-1680.
30. Lee EJ, Seo SR, Um JW, Park J, Oh Y, Chung KC. 2008. NF-κB-inducing kinase phosphorylates and blocks the degradation of Down syndrome candidate region 1. J Biol Chem 283:3392-3400.
31. Liu Q, Busby JC, Molkentin JD. 2009a. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signaling nodal control point. Nat Cell Biol 11:154-161.
32. Liu N, Li H, Li S, Shen M, Xiao N, Chen Y, Wang Y, Wang W, Wang R, Wang Q, Sun J, Wang P. 2010. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs. J Biol Chem 285:18858-18867.
33. Liu H, Wang P, Song W, Sun X. 2009b. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy ubiquitin proteasome pathways. FASEB J 23:3383-3392.
34. Love KR, Catic A, Schlieker C, Ploegh HL. 2007. Mechanisms, biology and inhibitors of deubiquitinating enzymes. Nat Chem Biol 3:697-705.
35. Medh RD, Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG, Luxon BA, Thompson EB. 2003. Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid evoked apoptosis. Genomics 81:543-555.
36. Miranda M, Sorkin A. 2007. Regulation of receptors and transporters by ubiquitination: New insights into surprisingly similar mechanisms. Mol Interv 7:157-167.
37. Nateri AS, Riera-Sans L, Da Costa C, Behrens A. 2004. The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303:1374-1378.
38. Noh EH, Hwang HS, Hwang HS, Min BR, Im E, Chung KC. 2012. Covalent NEDD8 conjugation increases protein stability potentiates its inhibitory action on calcineurin. PLoS ONE 7:e48315.
39. Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U. 2001. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem 276:35847-35853.
40. Park J, Oh Y, Chung KC. 2009. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1. BMB Rep 42:6-15.
41. Pijnappel WW, Timmers HT. 2008. Dubbing SAGA unveils new epigenetic crosstalk. Mol Cell 29:152-154.
42. Reyes-Turcu FE, Ventii KH, Wilkinson KD. 2009. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 78:363-397.
43. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS. 2000. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275:8719-8725.
44. Schoneveld OJ, Gaemers IC, Lamers WH. 2004. Mechanisms of glucocorticoid signaling. Biochim Biophys Acta 1680:114-128.
45. Seo SR, Chung KC. 2008. CREB activates proteasomal degradation of DSCR1/RCAN1. FEBS Lett 582:1889-1893.
46. Thompson EB, Webb MS, Miller AL, Fofanov Y, Johnson BH. 2004. Identification of genes leading to glucocorticoid-induced leukemic cell death. Lipids 39:821-825.
47. Wyce A, Henry KW, Berger SL. 2004. H2B ubiquitylation and de-ubiquitylation in gene activation. Novartis Found Symp 259:63-73.
48. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI. 2004. Phosphorylation-dependentdegradation ofc-Myc is mediated by the protein Fbw7. EMBO J 23:2116-2125.
49. Yao YG, Duh EJ. 2004. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: A mechanism for feedback regulation of angiogenesis. Biochem Biophys Res Commun 321:648-656.
50. Ye Y, Blaser G, Horrocks MH, Ruedas-Rama MJ, Ibrahim S, Zhukov AA, Orte A, Klenerman D, Jackson SE, Komander D. 2012. Ubiquitin chain conformation regulates recognition and activity of interacting proteins. Nature 492:266-270.
51. Zhang XY, Varthi M, Sykes SM, Phillips C, Warzecha C, Zhu W, Wyce A, Thorne AW, McMahon SB. 2008. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol Cell 29:102-111.
52. Zhao Y, Lang G, Ito S, Bonnet J, Metzger E, Sawatsubashi S, Suzuki E, Le Guezennec X, Stunnenberg HG, Krasnov A, Georgieva SG, Schuele R, Takeyama K, Kato S, Tora L, Devys D. 2008. A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing. Mol Cell 29:92-101.
53. Zhao D, Zheng HQ, Zhou Z, Chen C. 2010. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation. Cancer Res 70:4728-4738.